[Leakadin immunotherapy in the combined therapy of acoustic neurinomas].
The paper specifies the role of leacadin immunotherapy in combined treatment of acoustic nerve neurinomas. The antitumor immunomodulator leacadin contributes to establishment and consolidation of the tumor carrier's immunological adaptation which results in uneventful postoperative developments and recurrent-free survival.
A A
AA
Starchenko
V A
VA
Khil'ko
S A
SA
Komarets
A N
AN
Khlunovskiĭ
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001388:Aziridines / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D009464:Neuroma, Acoustic / Q000276:immunology / Q000628:therapy*; D011182:Postoperative Care; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D001388:Aziridines; C055240:Leakadine
Immunoterapiia leakadinom v kompleksnoĭ terapii nevrinom slukhovogo nerva.